Full text link below to a review article just published in Current Pulmonary Reports on Non-Specific Pleuritis. A key topic for those interested in #mesothelioma evolution. Well done to first author Mark Neilly and thanks to our co-author and pathology colleague, Craig Dick 👏 rdcu.be/d9Fgg

Great to be in beautiful Edinburgh for the National #Mesothelioma Education Day 2025 🏴󠁧󠁢󠁳󠁣󠁴󠁿 Dr Neil McGlinchey kicking off the meeting in fantastic setting at Royal College of Physicians

Looking forward to this tomorrow ⬇️ National #Mesothelioma Network Education Day ✅ New Management Guideline 🩻 New Staging (TNM 9) 📈 Review of Audit Performance (QPI) Plus Trials, Interventional Pain, Pleural Nursing & Horizon scanning …then, dinner with team 🎉🍷

Check out this interview with our #PREDICTMeso PI @kevingblyth.bsky.social discussing #mesothelioma; why it takes so long to develop, and what we at @predict-meso.bsky.social are doing to research and develop new treatments #MesotheliomaResearch #MesoORIGINS #CancerResearch #EarlyDetection

A few mins of #Mesothelioma chat starts @1251 on BBC Scotland Lunchtime Live👇 Why does meso develop decades after exposure? What are we doing in @predict-meso.bsky.social to develop new treatments? @uofglasgow.bsky.social @cruk-si.bsky.social @cancerresearchuk.org www.bbc.co.uk/sounds/play/...

Looking forward to talking #mesothelioma on BBC Scotland Lunchtime Live in a few minutes!

There are now 24 step-by-step guides, explaining how to create these ⬇️ data visualizations with R/ggplot2 - I hope this is a useful resource. Find them all here: joachimgoedhart.github.io/DataViz-prot...

Article in @heraldscotland.bsky.social this week highlights a sad #mesothelioma story & ongoing research in PREDICT-Meso, IAMMED, Meso-SCAPE & excellent Hansen lab @predict-meso.bsky.social @djmurphylab2.bsky.social @cruk-si.bsky.social www.heraldscotland.com/news/2477596...

It was great to be part of the BTOG/MesoUK Essential Update meeting this week Topics included diagnostics, new Rx, CNS roles, legal, pleural Nice to see 2 current PhD students presenting 🏴󠁧󠁢󠁳󠁣󠁴󠁿 Meso Network (Matt) 🧬 PREDICT-Meso (Mark) @btog.bsky.social @mesouk.bsky.social @uofglasgow.bsky.social

Very proud of Jenny Ferguson - PhD viva passed today! 🎉🥂 Her thesis on stratification of #respiratory disease covered 🫁 STRATIFY trial of #pleural staging in Lung Ca 🔬Predictive Markers in #MPE 🦠 Immune markers of severe #COVID19 🙏 R Bhatnagar, C Church & L Richmond! @uofglasgow.bsky.social

🟡 Recruiting now – PREDICT-Meso PPI Group People affected my mesothelioma to join a new PPI group to advise on all stages of mesothelioma research.   Message us or visit our website… www.researchforthefuture.org/studies/predict-meso

New paper from our group on body composition changes in #mesothelioma during chemo ⬇️ 💪 61.5% patients lost muscle 🧈 60.4% patients lost fat 🫁 Extreme thoracic muscle loss & total fat loss independently prognostic Funded by Asthma+Lung UK www.sciencedirect.com/science/arti...

Kevin Blyth: management of mesothelioma effusion 🔹IPC vs pleurodesis = equivalent efficacy For pleurodesis: 🔹 Talc = most effective agent 🔹 Big drain no better than smaller ones 🔹 NSAIDs fine for analgesia (won’t limit pleurodesis) 🔹 Talc slurry as good as poudrage

@dean_fennell: 2L mesothelioma options 👉 (small) subset of non-epithelioid pts do very well with Vin 🟢 Gem+Ramucirumab = ⬆️ PFS ❓ Gem maintenance = ⬆️ PFS, but a bit forgotten 🟢 Platinum rechallenge RR 50% ❓Activity in immuno rechallenge, RR up to 50%

Improve your mesothelioma service by forming a network: the 🏴󠁧󠁢󠁳󠁣󠁴󠁿 experience by Matthew Tate 🟢 ⬆️ data completeness 🟢 ⬇️ non-biopsy cases 🟢 ⬆️ OS in non-epithelioid 🔺 OS benefit not solely due to arrival of immunotherapy @btog.bsky.social @mesouk.bsky.social

PREDICT-Meso: 🧐 How does inflammation evolve into malignancy? 🧐 Can we diagnose mesothelioma at pre-malignant stage? 👉 80 institutions, 16 countries 👉 x5 work streams Fantastic, ambitious, international, multi-faceted project @btog.bsky.social @mesouk.bsky.social

Matthew Tate presenting outcomes from the Scottish #Mesothelioma Network ⬆️ Overall Survival in Non-Epi cases ⬆️ Use of Immunotherapy ⬆️ OS in Non-Epi cases not receiving IO Mesothelioma networks should be developed across the UK

Was that a collective sigh of relief, I heard?

On-call week for me at #QEUH Lots of Flu A! 🦠😷 Felt like every other patient today. Will be interested to see if the upward trend in last weeks numbers continues publichealthscotland.scot/publications...

Can you believe it, it’s almost December! This year we’re excited to bring you a #RespMas advent calendar! Every day we’ll open a window to reveal a paper worth reading! By Christmas we’ll all be on top of our Respiratory game! #medsky #pulmsky #lungsky #RespEd #RespIsBest

This is why we are all in this field…to see, and one day to be able to produce work like this. Patho-DBiT-seq www.cell.com/cell/fulltex...

Heading home after a fantastic #BTSWinter2024 Leaving energised and grateful for friends and the opportunity to talk #mesothelioma in the Plenary Scientific Symposium. Also excited for 2025 under our new BTS President!

This morning I presented results of the STRATIFY multi-centre trial of staging thoracoscopy for minimal pleural effusion in lung cancer. The prevalence of occult pleural mets was only 14%, thoracoscopy was safe & altered treatment plans. Paper coming soon! #BTSWinter2024 x.com/UKPleura/sta...

I'm very grateful to Asthma & Lung UK for the early support they provided to our now international #mesothelioma research program. Pump-priming is such an impactful strategy for grant-awarding charities x.com/IanJarroldAL...

Day 2 of #WinterBTS2024 started with a sunny walk in followed by presentation of STRATIFY results (pleural staging of Mini-PE). Next up is #mesothelioma presentation at Plenary Scientific Symposium 😬

This is starting now at #BTSwinter2024 in Windsor on 5th floor!

For anyone attending the Winter BTS meeting next week, we're having a Meso-ORIGINS study investigators' meeting on Wed 27th Nov. 1230-130pm, Rutherford Room on L4. Come and join if you're involved or just interested! #mesothelioma

First post on Bluesky, let’s share some websites offering many free illustrations for scientific figures 🖼️ 🧪 🌍 : scidraw.io bioart.niaid.nih.gov www.phylopic.org More well known but very nice though: www.freepik.com

Amazing study from colleagues at @uofglasgow.bsky.social @cruk-si.bsky.social reporting a histomorphological atlas of #mesothelioma Survival prediction + new biological insights via self-supervised AI. Excited to see how it performs on pre-meso biopsies! #PREDICT-Meso www.biorxiv.org/content/bior...

I started a #mesothelioma researcher starter pack Who have I missed? go.bsky.app/EvS1KrK

Nice study published yesterday in Science identifying Platelet Factor-4 as a potential mediator of Treg immune suppression by TAMs www.science.org/doi/10.1126/... Macrophages are prominent in the #mesothelioma TME due to frustrated phagocytosis of #asbestos fibres. Worth a closer 👀 #PREDICT-Meso

I like to think my research is patient centred - turns out it is! This is a great tool to visually summarise your publishing history (PubMed or Google Scholar) scholargoggler.com Boring text version here pubmed.ncbi.nlm.nih.gov?term=Blyth+K...

It’s that time of the year again 🥶 🌨️Pick your favourite Scottish road gritter name! 🏴󠁧󠁢󠁳󠁣󠁴󠁿 Check out the live tracker for a laugh www.traffic.gov.scot/gritter-trac... Difficult to look beyond #spreadymercury #kevinfridges #buzziceclear

On Wednesday this week we hosted our first PREDICT-Meso Young Investigators’ Day in Glasgow. Blown away by the progress and quality of our PhD students & postdocs. The future of #mesothelioma research looks bright! @cruk-si.bsky.social @uofglasgow.bsky.social @djmurphylab2.bsky.social

Are you a medic wanting to do a PhD in mesothelioma biology at the University of Cambridge? Deadline 19 November 2024 (Please send to colleagues you think might be interested) crukcambridgecentre.org.uk/sites/defaul...